Identification and characterization of the anti-viral interferon lambda 3 as direct target of the Epstein-Barr virus microRNA-BART7-3p

References

• Dunmire SK, Verghese PS, Balfour HH Jr. Primary Epstein-Barr virus infection. J Clin Virol. 2018;102:84–10. doi:10.1016/j.jcv.2018.03.001.
   PubMed Web of Science ®Google Scholar
• Bauer M, Jasinski-Bergner S, Mandelboim O, Wickenhauser C, Seliger B. Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies. Cancers Basel. 2021;13(20):5189. doi:10.3390/cancers13205189.
   PubMed Web of Science ®Google Scholar
• Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med. 1995;333(11):693–698. doi:10.1056/NEJM199509143331103.
   PubMed Web of Science ®Google Scholar
• Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol. 1992;140:769–774.
   PubMed Web of Science ®Google Scholar
• Huang X, Nolte I, Gao Z, Vos H, Hepkema B, Poppema S, van den Berg A, Diepstra A, Zhang L. Epidemiology of classical Hodgkin lymphoma and its association with Epstein Barr virus in Northern China. PLoS ONE. 2011;6(6):e21152. doi:10.1371/journal.pone.0021152.
   PubMed Web of Science ®Google Scholar
• Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer. 2008;123(11):2658–2663. doi:10.1002/ijc.23800.
   PubMed Web of Science ®Google Scholar
• Jasinski-Bergner S, Blumke J, Bauer M, Skiebe SL, Mandelboim O, Wickenhauser C, Seliger B. Novel approach to identify putative Epstein–Barr–virus microRNAs regulating host cell genes with relevance in tumor biology and immunology. Oncoimmunology. 2022;11(1):2070338. doi:10.1080/2162402X.2022.2070338.
   PubMed Web of Science ®Google Scholar
• Jasinski-Bergner S, Mandelboim O, Seliger B. Molecular mechanisms of human herpes viruses inferring with host immune surveillance. J Immunother Cancer. 2020;8(2):e000841. doi:10.1136/jitc-2020-000841.
   PubMed Web of Science ®Google Scholar
• Thorley-Lawson DA. EBV persistence–introducing the virus. Curr Top Microbiol Immunol. 2015;390(Pt 1):151–209.
   PubMedGoogle Scholar
• Xia T, O’Hara A, Araujo I, Barreto J, Carvalho E, Sapucaia JB, Ramos JC, Luz E, Pedroso C, Manrique M, et al. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 2008;68(5):1436–1442. doi:10.1158/0008-5472.CAN-07-5126.
   PubMed Web of Science ®Google Scholar
• Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Martin L, et al. Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8 + T cells. Proceedings of the National Academy of Sciences USA. 2016;113(42):E6467–E6475. doi:10.1073/pnas.1605884113.
   PubMed Web of Science ®Google Scholar
• Jasinski-Bergner S, Stoehr C, Bukur J, Massa C, Braun J, Huttelmaier S, Spath V, Wartenberg R, Legal W, Taubert H, et al. Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma. Oncoimmunology. 2015;4(6):e1008805. doi:10.1080/2162402X.2015.1008805.
   PubMed Web of Science ®Google Scholar
• Jasinski-Bergner S, Reches A, Stoehr C, Massa C, Gonschorek E, Huettelmaier S, Braun J, Wach S, Wullich B, Spath V, et al. Identification of novel microRNAs regulating HLA-G expression and investigating their clinical relevance in renal cell carcinoma. Oncotarget. 2016;7(18):26866–78.
   Google Scholar
• Jasinski-Bergner S, Mandelboim O, Seliger B. The role of microRNAs in the control of innate immune response in cancer. J Natl Cancer Inst. 2014;106(10): doi:10.1093/jnci/dju257.
   PubMedGoogle Scholar
• Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005;33(20):e179. doi:10.1093/nar/gni178.
   PubMed Web of Science ®Google Scholar
• WHO classification of tumours of haematopoietic and lymphoid tissues, NLM ID: 101716000, ISBN: 9789283244943.
   Google Scholar
• WHO Classification of Head and Neck Tumours. WHO/IARC classification of tumours. Vol. 9. 4th ed. 2017.
   Google Scholar
• Wu X, Cheng YL, Matthen M, Yoon A, Schwartz GK, Bala S, Taylor AM, Momen-Heravi F. Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion. J Exp Clin Cancer Res. 2021;40(1):70. doi:10.1186/s13046-021-01865-2.
   PubMed Web of Science ®Google Scholar
• Andreakos E, Salagianni M, Galani IE, Koltsida O. Interferon-λs: Front-line Guardians of Immunity and homeostasis in the respiratory tract. Front Immunol. 2017;8:1232. doi:10.3389/fimmu.2017.01232.
   PubMed Web of Science ®Google Scholar
• Rosa F, Berissi H, Weissenbach J, Maroteaux L, Fellous M, Revel M. The beta2-microglobulin mRNA in human Daudi cells has a mutated initiation codon but is still inducible by interferon. EMBO J. 1983;2(2):239–243. doi:10.1002/j.1460-2075.1983.tb01412.x.
   PubMed Web of Science ®Google Scholar
• Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA. 2004;10(10):1507–1517. doi:10.1261/rna.5248604.
   PubMed Web of Science ®Google Scholar
• Tierney RJ, Shannon-Lowe CD, Fitzsimmons L, Bell AI, Rowe M. Unexpected patterns of Epstein–Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA. Virology. 2015;474:117–130. doi:10.1016/j.virol.2014.10.030.
   PubMed Web of Science ®Google Scholar
• Kang MS, Kieff E. Epstein–Barr virus latent genes. Experimental & Molecular Medicine. 2015;47(1):e131. doi:10.1038/emm.2014.84.
   PubMedGoogle Scholar
• Yamamura S, Saini S, Majid S, Hirata H, Ueno K, Chang I, Tanaka Y, Gupta A, Dahiya R. MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis. 2012;33(2):294–300. doi:10.1093/carcin/bgr286.
   PubMed Web of Science ®Google Scholar
• Hong DS, Kang YK, Borad M, Sachdev J, Ejadi S, Lim HY, Brenner AJ, Park K, Lee JL, Kim TY, et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer. 2020;122(11):1630–1637. doi:10.1038/s41416-020-0802-1.
   PubMed Web of Science ®Google Scholar
• Peterson ST, Kennedy EA, Brigleb PH, Taylor GM, Urbanek K, Bricker TL, Lee S, Shin H, Dermody TS, Boon ACM, et al. Disruption of type III interferon (IFN) genes Ifnl2 and Ifnl3 recapitulates loss of the type III IFN receptor in the mucosal antiviral response. J Virol. 2019;93(22). doi:10.1128/JVI.01073-19.
   PubMed Web of Science ®Google Scholar
• Walker FC, Sridhar PR, Baldridge MT. Differential roles of interferons in innate responses to mucosal viral infections. Trends Immunol. 2021;42(11):1009–1023. doi:10.1016/j.it.2021.09.003.
   PubMed Web of Science ®Google Scholar